State Of Wyoming Adaptimmune Therapeutics PLC Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.28 $844 - $1,447	-635 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.73 - $4.06 $185 - $434	107 Added 20.27%	635 $1,000
Q4 2021 Feb 11, 2022	SELL	$3.5 - $5.68 $101 - $164	-29 Reduced 5.21%	528 $2,000
Q3 2021 Feb 11, 2022	SELL	$3.44 - $6.37 $921 - $1,707	-268 Reduced 32.48%	557 $3,000
Q2 2021 Feb 11, 2022	BUY	$3.86 - $5.78 $3,184 - $4,768	825 New	825 $4,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $114M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.